• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    GlucoTrack, Inc. - Common Stock (NQ:GCTK)

    0.4830 -0.1670 (-25.69%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 18, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,062,491
    Open 0.6508
    Bid (Size) 0.4822 (100)
    Ask (Size) 0.4861 (600)
    Prev. Close 0.6500
    Today's Range 0.4620 - 0.6508
    52wk Range 0.5800 - 15.90
    Shares Outstanding 910,688
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology
    Submission supports advancement of a long‑term, fully implantable, blood‑based continuous glucose monitoring platform 
    From Glucotrack, Inc.
    Via GlobeNewswire
    Wednesday's session: most active stocks ↗
    Via Chartmill

    Performance

    YTD
    -87.6%
    -87.6%
    1 Month
    -39.5%
    -39.5%
    3 Month
    -71.9%
    -71.9%
    6 Month
    -90.7%
    -90.7%
    1 Year
    -94.4%
    -94.4%

    More News

    Read More
    Unusual volume stocks in Wednesday's session ↗
    Via Chartmill
    Keep an eye on the top gainers and losers in Wednesday's session. ↗
    Via Chartmill
    Wednesday's session: gap up and gap down stocks ↗
    Via Chartmill
    These stocks are moving in today's pre-market session ↗
    Via Chartmill
    News headline image
    Glucotrack Announces Publication of Peer-Reviewed Study In The Journal of Diabetes Research Demonstrating Long-Term Accuracy and Stability of Continuous Blood Glucose Monitoring Technology
    From Glucotrack, Inc.
    Via GlobeNewswire
    Get insights into the top gainers and losers of Thursday's pre-market session. ↗
    Via Chartmill
    Check out the stocks that are attracting the most attention and driving market activity. ↗
    Via Chartmill
    Get insights into the top gainers and losers of Wednesday's pre-market session. ↗
    Via Chartmill
    News headline image
    Glucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology
    From Glucotrack, Inc.
    Via GlobeNewswire
    News headline image
    Tuesday's session: gap up and gap down stocks ↗
    Via Chartmill
    News headline image
    Stay updated with the stocks that are on the move in today's pre-market session. ↗
    Via Chartmill
    News headline image
    These stocks are moving in today's after hours session ↗
    Via Chartmill
    News headline image
    What's going on in today's session ↗
    Via Chartmill
    Stay updated with the stocks that are on the move in today's pre-market session. ↗
    Via Chartmill
    Monday's after hours session: top gainers and losers ↗
    Via Chartmill
    Which stocks are experiencing notable movement on Monday? ↗
    Via Chartmill
    Here are the top movers in Monday's session. ↗
    Via Chartmill
    Which stocks are gapping on Friday? ↗
    Via Chartmill
    What's going on in today's pre-market session ↗
    Via Chartmill
    News headline image
    Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones
    From Glucotrack, Inc.
    Via GlobeNewswire
    News headline image
    Glucotrack to Present at LSI USA ’26 Medtech Innovation Summit
    From Glucotrack, Inc.
    Via GlobeNewswire
    News headline image
    Why Did Glucotrack Stock Surge 12% Pre-Market Today? ↗
    Via Stocktwits
    Topics Intellectual Property
    News headline image
    Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform
    From Glucotrack, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is GlucoTrack, Inc. - Common Stock publicly traded?
    Yes, GlucoTrack, Inc. - Common Stock is publicly traded.
    What exchange does GlucoTrack, Inc. - Common Stock trade on?
    GlucoTrack, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for GlucoTrack, Inc. - Common Stock?
    The ticker symbol for GlucoTrack, Inc. - Common Stock is GCTK on the Nasdaq Stock Market
    What is the current price of GlucoTrack, Inc. - Common Stock?
    The current price of GlucoTrack, Inc. - Common Stock is 0.4830
    When was GlucoTrack, Inc. - Common Stock last traded?
    The last trade of GlucoTrack, Inc. - Common Stock was at 05/18/26 04:00 PM ET
    What is the market capitalization of GlucoTrack, Inc. - Common Stock?
    The market capitalization of GlucoTrack, Inc. - Common Stock is 439.86K
    How many shares of GlucoTrack, Inc. - Common Stock are outstanding?
    GlucoTrack, Inc. - Common Stock has 440K shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.